© Reuters. FILE PHOTO: Vials and medical syringe are seen in front of AstraZeneca logo in this illustration
(Reuters) – Britain’s Department of Health said on Sunday that medicines regulator MHRA (Medicines and Healthcare Products Regulatory Agency) must be given time to carry out its review of the data of the Oxford-AstraZeneca COVID-19 vaccine.
“We must now give the MHRA the time to carry out its important work and we must wait for its advice”, a Health Department spokeswoman said, commenting on a Sunday Telegraph report https:// that Britain will roll out the vaccine from Jan. 4.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.